Clin2
NCT07757555Possibly a fitNot yet recruiting

Two medicines for recent-onset POTS with allergy symptoms

Postural Orthostatic Tachycardia Syndrome (POTS)DysautonomiaOrthostatic IntoleranceAutonomic Nervous System Diseases

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This early-stage trial tests two medicines (guanfacine and cromolyn sodium) to see if they help with POTS symptoms like dizziness and rapid heartbeat. It's looking for people whose POTS started recently after a trigger and who may have signs of allergic-type reactions.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
25 people
Ages
18 years to 100 years
Study type
Interventional

Who can take part

  • You have a confirmed diagnosis of POTS, meaning your heart rate jumps by 30 beats per minute or more within 10 minutes of standing, and you don't have a big drop in blood pressure when standing.
  • You have symptoms like dizziness, heart palpitations, or stomach issues that have lasted at least 3 months.
  • Your symptoms started within 3 months after something like an infection, a vaccine, an injury, surgery, pregnancy, or reaching puberty.
  • You have symptoms like flushing, itching, hives, or swelling — or you've had a positive response to allergy-type medications.
  • You don't have another medical condition (like anemia, active infection, dehydration, thyroid issues, or certain tumors) that could explain your symptoms.
  • You're not pregnant or breastfeeding, and you're not taking any medications that can't be safely paused for the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07585513Not yet recruiting· Phase 2
Beta-blocker-like treatment for POTS

This study tests whether a daily pill called mirabegron can help control the rapid heartbeat and other symptoms of postural orthostatic tachycardia syndrome (POTS). If you join, you'll take the study drug or a placebo for a set time and track your symptoms.

NCT02725060Enrolling by invitation
Study of autoimmune changes in postural tachycardia syndrome

This trial studies whether an autoimmune (immune system–related) process is involved in postural tachycardia syndrome (POTS), a condition where your heart rate rises when you stand. The study may help researchers understand what causes POTS and how it could be treated or monitored.

Oklahoma City, Oklahoma
NCT07026643Not yet recruiting
New nerve treatment for POTS symptoms

This study tests a new treatment (called aVNT) for people with POTS, a condition that causes a rapid heart rate when standing up. It aims to see if this treatment can help reduce symptoms and improve daily functioning.

NCT07019519Recruiting
Gut hormones and blood flow in POTS

This study looks at how gut hormones control blood flow after eating in people with POTS. It may help explain symptoms like dizziness and rapid heartbeat after meals.

Copenhagen
NCT06936319Recruiting
Body movements for POTS symptom control

This study tests simple body movements (like squeezing your legs or squatting) to see if they help control POTS symptoms. It may offer a non-drug way to manage dizziness and fast heart rate when standing.

Innsbruck, Tyrol
NCT07163130Not yet recruiting
Ear stimulation for POTS treatment

This study tests if a gentle electrical stimulation near the ear (called tragus stimulation) can help with POTS symptoms, like dizziness and rapid heartbeat when standing. It aims to see if this non-invasive method can improve your daily life.

Hear when a new Dysautonomia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.